MMP9 and pulmonary emphysema: Compared to healthy controls, in patients with emphysema, AMs exhibit an increased production of matrix-degrading enzymes encompassing both collagenolytic and elastolytic activities in the BALF, along with increased MMP9 activity in the lung parenchyma, supporting the above observations [119,120].